Analytical Data
-
Gene name
SERTAD2
- Application
-
Alternative Names
SERTAD2;KIAA0127;TRIPBR2;SERTA domain-containing Protein 2
-
Species
Human
-
Source
E. coli
-
Tag
His tag N-Terminus
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q14140
-
Expression Region
1-314aa
-
AA Sequence
MGSSHHHHHHSSGLVPRGSHMGSMLGKGGKRKFDEHEDGLEGKIVSPCDG PSKVSYTLQRQTIFNISLMKLYNHRPLTEPSLQKTVLINNMLRRIQEELK QEGSLRPMFTPSSQPTTEPSDSYREAPPAFSHLASPSSHPCDLGSTTPLE ACLTPASLLEDDDDTFCTSQAMQPTAPTKLSPPALLPEKDSFSSALDEIE ELCPTSTSTEAATAATDSVKGTSSEAGTQKLDGPQESRADDSKLMDSLPG NFEITTSTGFLTDLTLDDILFADIDTSMYDFDPCTSSSGTASKMAPVSAD DLLKTLAPYSSQPVTPSQPFKMDLTELDHIMEVLVGS
-
Molecular Weight
36 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
SERTAD2 (SERTA domain containing 2) is a protein that plays a crucial role in various cellular processes, including cell proliferation, differentiation, and response to stress. As a member of the SERTAD family, SERTAD2 is known to interact with specific transcription factors and modulate their activity, thereby influencing gene expression and developmental pathways. Recent studies have implicated SERTAD2 in several key biological functions, including tumorigenesis, making it a significant focus of cancer research. Its involvement in signaling pathways associated with cell cycle regulation and apoptosis suggests that SERTAD2 could serve as a potential biomarker for certain cancers. Moreover, understanding the molecular mechanisms by which SERTAD2 exerts its functions may offer novel therapeutic targets for interventions in cancer and other diseases. The recombinant production of SERTAD2 enables detailed structural and functional analyses, paving the way for advanced studies on its interactions and regulatory roles in various physiological contexts. As the understanding of SERTAD2 expands, it may reveal further insights into its contributions to cellular homeostasis and disease progression, highlighting its potential as a target for future therapeutic strategies.
